Cargando…

Correction for Gan et al., An anti-CTLA-4 heavy chain–only antibody with enhanced T(reg) depletion shows excellent preclinical efficacy and safety profile

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Academy of Sciences 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962918/ https://www.ncbi.nlm.nih.gov/pubmed/36745818 http://dx.doi.org/10.1073/pnas.2219255119

Ejemplares similares

Correction for Gan et al., An anti-CTLA-4 heavy chain–only antibody with enhanced T(reg) depletion shows excellent preclinical efficacy and safety profile
Publicado: (2022)

An anti-CTLA-4 heavy chain–only antibody with enhanced T(reg) depletion shows excellent preclinical efficacy and safety profile
por: Gan, Xin, et al.
Publicado: (2022)

Heavy chain–only antibodies are spontaneously produced in light chain–deficient mice
por: Zou, Xiangang, et al.
Publicado: (2007)

Enhancement of electroporation facilitated immunogene therapy via T-reg depletion
por: Forde, P F, et al.
Publicado: (2014)

Production of Autoreactive Heavy Chain-Only Antibodies in Systemic Lupus Erythematosus
por: Xu, Shu, et al.
Publicado: (2020)

Improving CBCT image quality to the CT level using RegGAN in esophageal cancer adaptive radiotherapy
por: Wang, Hao, et al.
Publicado: (2023)

Expression of heavy chain‐only antibodies can support B‐cell development in light chain knockout chickens
por: Schusser, Benjamin, et al.
Publicado: (2016)

Using RegGAN to generate synthetic CT images from CBCT images acquired with different linear accelerators
por: Li, Zhenkai, et al.
Publicado: (2023)

Alpaca single B cell interrogation and heavy-chain-only antibody discovery on an optofluidic platform
por: Shapiro, Mariya B, et al.
Publicado: (2023)

Peripheral Blood from Rheumatoid Arthritis Patients Shows Decreased T(reg) CD25 Expression and Reduced Frequency of Effector T(reg) Subpopulation
por: Go, Eunbyeol, et al.
Publicado: (2021)

Anti-CTLA-4 antibodies in cancer immunotherapy: selective depletion of intratumoral regulatory T cells or checkpoint blockade?
por: Tang, Fei, et al.
Publicado: (2018)

Role and mechanism of REG2 depletion in insulin secretion augmented by glutathione peroxidase-1 overproduction
por: Yan, Xi, et al.
Publicado: (2022)

Expression Cloning and Production of Human Heavy-Chain-Only Antibodies from Murine Transgenic Plasma Cells
por: Drabek, Dubravka, et al.
Publicado: (2016)

Low‐dose interleukin‐2 promotes STAT‐5 phosphorylation, T(reg) survival and CTLA‐4‐dependent function in autoimmune liver diseases
por: Jeffery, H. C., et al.
Publicado: (2017)

Regeneration of the immunoglobulin heavy-chain repertoire after transient B-cell depletion with an anti-CD20 antibody
por: Rouzière, Anne-Sophie, et al.
Publicado: (2005)

CD25-T(reg)-depleting antibodies preserving IL-2 signaling on effector T cells enhance effector activation and antitumor immunity
por: Solomon, Isabelle, et al.
Publicado: (2020)

Synergy between chemotherapeutic agents and CTLA-4 blockade in preclinical tumor models
por: Jure-Kunkel, Maria, et al.
Publicado: (2013)

Investigation of Bulk Traps by Conductance Method in the Deep Depletion Region of the Al(2)O(3)/GaN MOS Device
por: Shi, Yuanyuan, et al.
Publicado: (2017)

Non-Buffer Epi-AlGaN/GaN on SiC for High-Performance Depletion-Mode MIS-HEMTs Fabrication
por: Zhang, Penghao, et al.
Publicado: (2023)

Scattering Analysis of AlGaN/AlN/GaN Heterostructures with Fe-Doped GaN Buffer
por: Arteev, Dmitri S., et al.
Publicado: (2022)

CTLA4 depletes T cell endogenous and trogocytosed B7 ligands via cis-endocytosis
por: Xu, Xiaozheng, et al.
Publicado: (2023)

SARS-CoV-2 neutralizing camelid heavy-chain-only antibodies as powerful tools for diagnostic and therapeutic applications
por: Schlör, Anja, et al.
Publicado: (2022)

Avidity engineering of human heavy-chain-only antibodies mitigates neutralization resistance of SARS-CoV-2 variants
por: Du, Wenjuan, et al.
Publicado: (2023)

Impact of CTLA-4 blockade in conjunction with metronomic chemotherapy on preclinical breast cancer growth
por: Parra, Karla, et al.
Publicado: (2017)

AlN formation by an Al/GaN substitution reaction
por: Noorprajuda, Marsetio, et al.
Publicado: (2020)

Crystal Structure and Characterization of Human Heavy-Chain Only Antibodies Reveals a Novel, Stable Dimeric Structure Similar to Monoclonal Antibodies
por: Mieczkowski, Carl, et al.
Publicado: (2020)

The effect of B-cell depletion with an anti-CD20 antibody on the immunoglobulin heavy-chain repertoire in a patient with rheumatoid arthritis
por: Rouzière, A-S, et al.
Publicado: (2005)

Role of Short Chain Fatty Acids in Controlling T(regs) and Immunopathology During Mucosal Infection
por: Bhaskaran, Natarajan, et al.
Publicado: (2018)

Controversial Canadian regs.
por: Fields, S
Publicado: (2001)

The mark of T reg cells
por: Van Epps, Heather L.
Publicado: (2005)

New target for T regs
por: Van Epps, Heather L.
Publicado: (2005)

Retargeted oncolytic adenovirus displaying a single variable domain of camelid heavy-chain-only antibody in a fiber protein
por: van Erp, Elisabeth A, et al.
Publicado: (2015)

High-grade glioma associated immunosuppression does not prevent immune responses induced by therapeutic vaccines in combination with T(reg) depletion
por: Löhr, Mario, et al.
Publicado: (2018)

The obesity-induced adipokine sST2 exacerbates adipose T(reg) and ILC2 depletion and promotes insulin resistance
por: Zhao, Xu-Yun, et al.
Publicado: (2020)

Evidences of CTLA-4 and PD-1 Blocking Agents-Induced Cardiotoxicity in Cellular and Preclinical Models
por: Quagliariello, Vincenzo, et al.
Publicado: (2020)

Genetic Removal of the CH1 Exon Enables the Production of Heavy Chain-Only IgG in Mice
por: Zhang, Tianyi, et al.
Publicado: (2018)

Anti-BCMA chimeric antigen receptors with fully human heavy-chain-only antigen recognition domains
por: Lam, Norris, et al.
Publicado: (2020)

An affinity-enhanced, broadly neutralizing heavy chain–only antibody protects against SARS-CoV-2 infection in animal models
por: Schepens, Bert, et al.
Publicado: (2021)

TLR1/2 ligand enhances antitumor efficacy of CTLA-4 blockade by increasing intratumoral Treg depletion
por: Sharma, Naveen, et al.
Publicado: (2019)

IPR{reg} : identificación del paciente en riesgo /
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_68okmlsm8r1rc102o0sduoj8nt